Cargando…

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a versatile and complicated profile, being the fourth most common single cause of death worldwide. Several research groups have been trying to identify possible therapeutic approaches to treat COPD, such as the use of mucoa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pace, Elisabetta, Cerveri, Isa, Lacedonia, Donato, Paone, Gregorino, Sanduzzi Zamparelli, Alessandro, Sorbo, Rossella, Allegretti, Marcello, Lanata, Luigi, Scaglione, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227620/ https://www.ncbi.nlm.nih.gov/pubmed/35745833 http://dx.doi.org/10.3390/pharmaceutics14061261

Ejemplares similares

Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy
por: Bianco, Andrea, et al.
Publicado: (2022)

Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study
por: Ferraro, Maria, et al.
Publicado: (2022)

Role of mucolytics in the management of COPD
por: Poole, Phillippa J
Publicado: (2006)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Palatability Assessment of Carbocysteine Oral Solution Strawberry Taste Versus Carbocysteine Oral Solution Mint Taste: A Blinded Randomized Study
por: Peng, Yaguang, et al.
Publicado: (2022)

Possible Role of Carbocysteine Syrup in the Deflation of Percutaneous Endoscopic Gastrostomy Balloons
por: Bassotti, Gabrio, et al.
Publicado: (2023)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2023)

Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial
por: Wu, Kang, et al.
Publicado: (2016)

Effects of a Long-Term Use of Carbocysteine on Frequency and Duration of Exacerbations in Patients with Bronchiectasis
por: Minov, Jordan, et al.
Publicado: (2019)

Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis
por: Giacon, Valeria, et al.
Publicado: (2021)

Efficacy of mucolytics and steam therapy in the management of sinusitis among Indians
por: S Balakrishnan, Rajalakshmi, et al.
Publicado: (2023)

New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach
por: Juergens, Lisa Joy, et al.
Publicado: (2020)

Analysis of Sputum Markers in the Evaluation of Lung Inflammation and Functional Impairment in Symptomatic Smokers and COPD Patients
por: Paone, Gregorino, et al.
Publicado: (2011)

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020)

Respiratory Paradoxical Adverse Drug Reactions Associated with Acetylcysteine and Carbocysteine Systemic Use in Paediatric Patients: A National Survey
por: Mallet, Pauline, et al.
Publicado: (2011)

A Quality Improvement Approach to Influence Value-based Mucolytic Use in the PICU
por: Gillis, Holly Catherine, et al.
Publicado: (2021)

A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]
por: Kurukulaaratchy, Ramesh J, et al.
Publicado: (2021)

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
por: Papadopoulou, Efthymia, et al.
Publicado: (2023)

Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
por: Patzwaldt, Kristin, et al.
Publicado: (2023)

A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases
por: Addante, Annalisa, et al.
Publicado: (2023)

Mucolytic treatment of chronic rhinosinusitis in a murine model of primary ciliary dyskinesia
por: Yin, Weining, et al.
Publicado: (2023)

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Association between COVID-19 and Sick Leave for Healthcare Workers in a Large Academic Hospital in Southern Italy: An Observational Study
por: Palladino, Raffaele, et al.
Publicado: (2022)

A conservative treatment for chronic obstructive sialoadenitis by intraductal instillation of mucolytic, steroids and antibiotic solution
por: Lorusso, Francesco, et al.
Publicado: (2021)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

A Phase II Study on the Effect of Taurisolo(®) Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2022)

Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype
por: Lacedonia, Donato, et al.
Publicado: (2017)

Mucolytics for Intubated Asthmatic Children: A National Survey of United Kingdom Paediatric Intensive Care Consultants
por: Snoek, Aarjan Peter, et al.
Publicado: (2015)

Taste Masked Orally Disintegrating Pellets of Antihistaminic and Mucolytic Drug: Formulation, Characterization, and In Vivo Studies in Human
por: Taj, Yasmeen, et al.
Publicado: (2014)

Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial
por: Koppitz, Martin, et al.
Publicado: (2016)

Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19
por: Coelho dos Reis, Jordana Grazziela A., et al.
Publicado: (2022)

Administration of maximum dose of mucolytic solution before upper endoscopy – a double-blind, randomized trial
por: Stepan, Michal, et al.
Publicado: (2023)

COPD: adherence to therapy
por: Sanduzzi, Alessandro, et al.
Publicado: (2014)

Mucolytics as Adjuvant Agent to Improve Helicobacter pylori Eradication Rate: Still Long and Winding Road to Positive Results
por: Yoon, Hyuk, et al.
Publicado: (2015)

Does Premedication with Mucolytic Agents Improve Mucosal Visualization during Oesophagogastroduodenoscopy: A Systematic Review and Meta-Analysis
por: Burke, Eoghan, et al.
Publicado: (2021)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
por: Mosella, Marco, et al.
Publicado: (2018)

May Polyphenols Have a Role Against Coronavirus Infection? An Overview of in vitro Evidence
por: Annunziata, Giuseppe, et al.
Publicado: (2020)

The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population
por: de Marco, Roberto, et al.
Publicado: (2013)

Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide
por: Su, Xiao, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_jkqu07hk37r329qnge6p9m1uab